How to treat recurrences after Avastin treatment for neovascular AMD: stick to Avastin or switch to Lucentis?
Wolf
A
A
Kook
D
D
Strauss
R
R
Kampik
A
A
Haritoglou
C
C
D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy*; D008297:Male; D000069579:Ranibizumab; D012189:Retrospective Studies; D055502:Secondary Prevention; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D000069579:Ranibizumab